Valuation

TECHBio-Techne

StockNasdaqUnited StatesHealth careEU retail: available
6/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricTECHSector medianvs median
P/E62.528.8 · n=114117% above
P/B5.43.0 · n=19679% above
P/S9.43.7 · n=202152% above
EV/EBIT44.924.1 · n=10386% above
Free-cash-flow yield2.3%2.8% · n=18717% below
Dividend yield0.44%0.00% · n=215—
Return on equity9.0%2.7% · n=193240% above
Return on invested capital8.5%3.5% · n=176139% above
Gross margin65.8%62.5% · n=1525% above
Net debt / EBITDA−0.191.19 · n=108116% below

Value factor: 40 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42.633.6—1.6%0.6%6/10
JNJJohnson & Johnson29.17.2—3.6%2.1%8/10
ABBVAbbVie79.9—33.53.6%3.0%5/10
MRKMerck114.68.7—4.4%2.3%8/10
UNHUnitedHealth25.13.418.66.7%2.3%9/10
TMOThermo Fisher Scientific35.74.735.22.9%0.3%8/10
AMGNAmgen26.319.724.04.4%2.3%6/10
GILDGILEAD—16.1—6.8%2.1%4/10
ABTAbbott28.53.426.84.1%3.0%5/10
PFEPfizer38.42.0—6.6%5.9%1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Jun 2026 · filed 24 Aug 2026